Leonard Heffner Jr., MD

Sponsored Research Projects

• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination with Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia
• A Phase 3, Randomized, Open Label Study Investigating the Efficacy of the BiTE Antibody Blinatumomab Versus Standard of Care Chemotherapy in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (TOWER Study)
• B1931022 - B1931022: An Open-label Randomized Phase 3 Study of Inotuzumab Ozogami
• BO25323/CLL14: A prospective, open-label, multicenter, randomized phase III trial
• PCI-32765CLL3001: Randomized, Double-blind, Placebo-controlled Phase 3 Study of Ib
• PCYC-1127-CA A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ibru